C2i Genomics Raises $100 Million To Commercialize the Detection of Tiny Traces of Cancer Using AI and Whole Genome Sequencing
Similar Posts
Honor™ Announces Innovative Partnership with the National Parkinson Foundation
Care Pros to deliver expert knowledge and care directly to people with Parkinson’s disease at home Honor™ (www.JoinHonor.com), a leader…
Teladoc Senior Vice President Dr. Alan Roga to Address Hospital and Health System Chief Financial Officers at J.P. Morgan Healthcare Advisory Council
Teladoc, Inc., the first and largest telehealth platform in the United States, announced that Alan Roga, MD, FACEP, Teladoc…
Rimidi and Companion Medical Announce First US Partnership to Bring Connected Insulin Data Into the Clinical Workflow
Healthcare technology takes step to improve outcomes for patients with Type 2 Diabetes in Southern California Rimidi, a cloud-based…
Concerto Cloud Services Launches the Concerto Cloud for Healthcare Featuring Industry-best Security, Compliance and Service
Healthcare delivery organizations, payers and technology companies now have a trusted partner and a hybrid cloud solution built for…
